Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Syntrix Biosystems, Inc.

Clinical trials sponsored by Syntrix Biosystems, Inc., explained in plain language.

Trials to join now! 2 Not yet finished but already full! 1

New drug trial aims to unleash immune system against skin cancer

Disease control Ongoing

This early-stage study is testing a new oral drug called SX-682 in people with advanced melanoma that has spread. The goal is to see if SX-682 can safely block certain cells that shield the tumor, allowing the patient's own immune system, boosted by an existing immunotherapy drug…

Phase: PHASE1 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC